article thumbnail

New Bill could enhance UK clinical trial regulation

European Pharmaceutical Review

This activity should bring together relevant data sets which are collected by both the Medicines and Healthcare products Regulatory Agency (MHRA) and HRA. A new sixty-day limit would be implemented for those conducting a trial to respond to Requests for Further Information (RFI) from the MHRA or Research Ethics Committees (RECs).

Ethics 83
article thumbnail

Cancer: Progress but a long way to go

World of DTC Marketing

In recent years, early detection and treatment improvements have helped boost the 3-year survival rate for lung cancer from 21% in 2004 to 31% in 2015 through 2017. In addition to a cancer “moonshot,” we need treatments that patients and our healthcare system can afford. American Cancer Society’s ACS ).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Preparing for stricter standards on substances of human origin

European Pharmaceutical Review

Overall, while the proposed regulation on SoHO may present some challenges for ATMP developers, it is also expected to ultimately improve patient safety and thus build trust not only in ATMPs, but also among patients and healthcare providers, which could ultimately benefit ATMP developers in the long run. Cited 2023Mar].

Safety 62
article thumbnail

Uri Goren

Cadensee

02:25 Uri Goren talks about his road to become a trailblazer and advocate for patient-centric healthcare. 52:21 Uri's opinion about the main problem that needs to be solved for the healthcare market with technology. When he was going through his cancer, he died in 2004. Interview Transcription (mild edits).